Calithera Biosciences Ownership 2024 | Who Owns Calithera Biosciences Now?
Institutional Ownership
0.00%
Insider Ownership
1.07%
Institutional Holders
1.00
Calithera Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FINTRUST CAPITAL ADVISORS, LLC | 0.02% | 0.00% | 1,201 | - | - | 3,916,000 | Mar 31, 2023 |
| MORGAN STANLEY | - | - | - | -697 | -100.00% | - | Mar 31, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -199,269 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -321 | -100.00% | - | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -539 | -100.00% | - | Mar 31, 2023 |
| TRUVESTMENTS CAPITAL LLC | - | - | - | -52 | -100.00% | - | Mar 31, 2023 |
| JPMORGAN CHASE & CO | - | - | - | -24,342 | -100.00% | - | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -3,782 | -100.00% | - | Mar 31, 2023 |
| COPPELL ADVISORY SOLUTIONS CORP. | - | - | - | -675 | -100.00% | - | Mar 31, 2023 |
| BVF INC/IL | - | - | - | -464,742 | -100.00% | - | Mar 31, 2023 |
| ARCUS CAPITAL PARTNERS, LLC | - | - | - | -250 | -100.00% | - | Mar 31, 2023 |
| CITIGROUP INC | - | - | - | -14 | -100.00% | - | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -660 | -100.00% | - | Mar 31, 2023 |
| STATE STREET CORP | - | - | - | -10,805 | -100.00% | - | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -66,795 | -100.00% | - | Mar 31, 2023 |
| QUENT CAPITAL, LLC | - | - | - | -2 | -100.00% | - | Mar 31, 2023 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -155,070 | -100.00% | - | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -29,176 | -100.00% | - | Mar 31, 2023 |
| VANGUARD GROUP INC | - | - | - | -47,169 | -100.00% | - | Mar 31, 2023 |
| TSP CAPITAL MANAGEMENT GROUP, LLC | - | - | - | -44,750 | -100.00% | - | Mar 31, 2023 |
Calithera Biosciences's largest institutional shareholder is FINTRUST CAPITAL ADVISORS, LLC, holding 0.02% of the company's total share outstanding, currently valued at $3.92M. The top 10 institutional shareholders own together 0.02% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FINTRUST CAPITAL ADVISORS, LLC | 0.02% | 0.00% | 1,201 | - | - | 3,916,000 | Mar 31, 2023 |
| MORGAN STANLEY | - | - | - | -697 | -100.00% | - | Mar 31, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -199,269 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -321 | -100.00% | - | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -539 | -100.00% | - | Mar 31, 2023 |
| TRUVESTMENTS CAPITAL LLC | - | - | - | -52 | -100.00% | - | Mar 31, 2023 |
| JPMORGAN CHASE & CO | - | - | - | -24,342 | -100.00% | - | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -3,782 | -100.00% | - | Mar 31, 2023 |
| COPPELL ADVISORY SOLUTIONS CORP. | - | - | - | -675 | -100.00% | - | Mar 31, 2023 |
| BVF INC/IL | - | - | - | -464,742 | -100.00% | - | Mar 31, 2023 |
| ARCUS CAPITAL PARTNERS, LLC | - | - | - | -250 | -100.00% | - | Mar 31, 2023 |
| CITIGROUP INC | - | - | - | -14 | -100.00% | - | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -660 | -100.00% | - | Mar 31, 2023 |
| STATE STREET CORP | - | - | - | -10,805 | -100.00% | - | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -66,795 | -100.00% | - | Mar 31, 2023 |
| QUENT CAPITAL, LLC | - | - | - | -2 | -100.00% | - | Mar 31, 2023 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -155,070 | -100.00% | - | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -29,176 | -100.00% | - | Mar 31, 2023 |
| VANGUARD GROUP INC | - | - | - | -47,169 | -100.00% | - | Mar 31, 2023 |
| TSP CAPITAL MANAGEMENT GROUP, LLC | - | - | - | -44,750 | -100.00% | - | Mar 31, 2023 |
The largest Calithera Biosciences shareholder by % of total assets is FINTRUST CAPITAL ADVISORS, LLC. The company owns 1.20K shares of Calithera Biosciences (CALA), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FINTRUST CAPITAL ADVISORS, LLC | 0.02% | 0.00% | 1,201 | - | - | 3,916,000 | Mar 31, 2023 |
| QUENT CAPITAL, LLC | - | - | - | -2 | -100.00% | - | Mar 31, 2023 |
| CITIGROUP INC | - | - | - | -14 | -100.00% | - | Mar 31, 2023 |
| TRUVESTMENTS CAPITAL LLC | - | - | - | -52 | -100.00% | - | Mar 31, 2023 |
| ARCUS CAPITAL PARTNERS, LLC | - | - | - | -250 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -321 | -100.00% | - | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -539 | -100.00% | - | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -660 | -100.00% | - | Mar 31, 2023 |
| COPPELL ADVISORY SOLUTIONS CORP. | - | - | - | -675 | -100.00% | - | Mar 31, 2023 |
| MORGAN STANLEY | - | - | - | -697 | -100.00% | - | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -3,782 | -100.00% | - | Mar 31, 2023 |
| STATE STREET CORP | - | - | - | -10,805 | -100.00% | - | Mar 31, 2023 |
| JPMORGAN CHASE & CO | - | - | - | -24,342 | -100.00% | - | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -29,176 | -100.00% | - | Mar 31, 2023 |
| TSP CAPITAL MANAGEMENT GROUP, LLC | - | - | - | -44,750 | -100.00% | - | Mar 31, 2023 |
| VANGUARD GROUP INC | - | - | - | -47,169 | -100.00% | - | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -66,795 | -100.00% | - | Mar 31, 2023 |
| BLACKROCK INC. | - | - | - | -83,839 | -100.00% | - | Mar 31, 2023 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -155,070 | -100.00% | - | Mar 31, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -199,269 | -100.00% | - | Mar 31, 2023 |
As of Mar 31 2023, Calithera Biosciences's largest institutional buyer is FINTRUST CAPITAL ADVISORS, LLC. The company purchased 0.00 stocks of CALA, valued at $3.92M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BVF INC/IL | - | - | - | -464,742 | -100.00% | - | Mar 31, 2023 |
| PRIMECAP MANAGEMENT CO/CA/ | - | - | - | -401,080 | -100.00% | - | Mar 31, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -199,269 | -100.00% | - | Mar 31, 2023 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -155,070 | -100.00% | - | Mar 31, 2023 |
| BLACKROCK INC. | - | - | - | -83,839 | -100.00% | - | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -66,795 | -100.00% | - | Mar 31, 2023 |
| VANGUARD GROUP INC | - | - | - | -47,169 | -100.00% | - | Mar 31, 2023 |
| TSP CAPITAL MANAGEMENT GROUP, LLC | - | - | - | -44,750 | -100.00% | - | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -29,176 | -100.00% | - | Mar 31, 2023 |
| JPMORGAN CHASE & CO | - | - | - | -24,342 | -100.00% | - | Mar 31, 2023 |
| STATE STREET CORP | - | - | - | -10,805 | -100.00% | - | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -3,782 | -100.00% | - | Mar 31, 2023 |
| MORGAN STANLEY | - | - | - | -697 | -100.00% | - | Mar 31, 2023 |
| COPPELL ADVISORY SOLUTIONS CORP. | - | - | - | -675 | -100.00% | - | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -660 | -100.00% | - | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -539 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -321 | -100.00% | - | Mar 31, 2023 |
| ARCUS CAPITAL PARTNERS, LLC | - | - | - | -250 | -100.00% | - | Mar 31, 2023 |
| TRUVESTMENTS CAPITAL LLC | - | - | - | -52 | -100.00% | - | Mar 31, 2023 |
| CITIGROUP INC | - | - | - | -14 | -100.00% | - | Mar 31, 2023 |
As of Mar 31 2023, Calithera Biosciences's biggest institutional seller is BVF INC/IL. The company sold -0.46M shares of CALA, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BVF INC/IL | - | - | - | -464,742 | -100.00% | - | Mar 31, 2023 |
| PRIMECAP MANAGEMENT CO/CA/ | - | - | - | -401,080 | -100.00% | - | Mar 31, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -199,269 | -100.00% | - | Mar 31, 2023 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -155,070 | -100.00% | - | Mar 31, 2023 |
| BLACKROCK INC. | - | - | - | -83,839 | -100.00% | - | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -66,795 | -100.00% | - | Mar 31, 2023 |
| VANGUARD GROUP INC | - | - | - | -47,169 | -100.00% | - | Mar 31, 2023 |
| TSP CAPITAL MANAGEMENT GROUP, LLC | - | - | - | -44,750 | -100.00% | - | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -29,176 | -100.00% | - | Mar 31, 2023 |
| JPMORGAN CHASE & CO | - | - | - | -24,342 | -100.00% | - | Mar 31, 2023 |
| STATE STREET CORP | - | - | - | -10,805 | -100.00% | - | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -3,782 | -100.00% | - | Mar 31, 2023 |
| MORGAN STANLEY | - | - | - | -697 | -100.00% | - | Mar 31, 2023 |
| COPPELL ADVISORY SOLUTIONS CORP. | - | - | - | -675 | -100.00% | - | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -660 | -100.00% | - | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -539 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -321 | -100.00% | - | Mar 31, 2023 |
| ARCUS CAPITAL PARTNERS, LLC | - | - | - | -250 | -100.00% | - | Mar 31, 2023 |
| TRUVESTMENTS CAPITAL LLC | - | - | - | -52 | -100.00% | - | Mar 31, 2023 |
| CITIGROUP INC | - | - | - | -14 | -100.00% | - | Mar 31, 2023 |
| QUENT CAPITAL, LLC | - | - | - | -2 | -100.00% | - | Mar 31, 2023 |
Calithera Biosciences's largest sold out institutional shareholder by shares sold is BVF INC/IL, sold -0.46M shares, valued at -, as of undefined.
Calithera Biosciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| PRIMECAP Odyssey Funds | 0.91% | 7,439,400 | - | - | Jan 31, 2024 |
| Federated Hermes Equity Funds | 0.34% | 6,591,567 | - | - | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.08% | 183,500 | - | - | Mar 28, 2024 |
| ETFis Series Trust I | 0.04% | 62,552 | - | - | Jan 31, 2024 |
| ALGER FUNDS | 0.02% | 20,000 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 11,637 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.02% | 174,841 | - | - | Mar 31, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.02% | 76,233 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 96,772 | - | - | Mar 31, 2024 |
| PRIMECAP Odyssey Funds | 0.02% | 126,712 | - | - | Jan 31, 2024 |
| Fidelity Commonwealth Trust II | 0.01% | 94,521 | - | - | Aug 31, 2023 |
| GABELLI EQUITY TRUST INC | 0.01% | 12,150 | - | - | Dec 29, 2023 |
| SSGA FUNDS | 0.01% | 4,234 | - | - | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,175 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 2,054,578 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.00% | 6,158 | - | - | Mar 28, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 129,548 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 509,345 | - | - | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 5,810 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 61,160 | - | - | Mar 31, 2024 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 32,598 | - | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 25,304 | - | - | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 46,356 | - | - | Feb 29, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 20,802 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 542 | - | - | Apr 30, 2021 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 32,133 | - | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 4,393 | - | - | Mar 31, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 36,231 | - | - | Mar 31, 2024 |
| GPS Funds I | 0.00% | 4,328 | - | - | Mar 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 3,210 | - | - | Mar 31, 2024 |
| GABELLI EQUITY TRUST INC | 0.00% | 607 | - | - | Dec 29, 2023 |
| Columbia Funds Variable Series Trust II | 0.00% | 13,841 | - | - | Mar 31, 2024 |
| AdvisorShares Trust | 0.00% | 1,527 | - | - | Mar 28, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 3,661 | - | - | Feb 29, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 17,825 | - | - | Mar 31, 2023 |
| Forethought Variable Insurance Trust | 0.00% | 1,099 | - | - | Mar 28, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 3,632 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 2,654 | - | - | Mar 31, 2024 |
| PGIM ETF TRUST | 0.00% | 12,713 | - | - | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 11,900 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 11,606 | - | - | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 470 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 148,024 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 27,194 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 1,427 | - | - | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 10,469 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 452,737 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 46,118 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 31,218 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 216,646 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 310,647 | - | - | Dec 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 3,058 | - | - | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 6,499 | - | - | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 12,048 | - | - | Mar 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 4,360 | - | - | Dec 31, 2023 |
| ETF Series Solutions | 0.00% | 1,695 | - | - | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 2,200 | - | - | Mar 28, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 8,959 | - | - | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 71,605 | - | - | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 2,065 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 190,740 | - | - | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 13,513 | - | - | Feb 29, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 13,782 | - | - | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 18,486 | - | - | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 9,099 | - | - | Jan 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 160 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 3,348 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 581 | - | - | Feb 29, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 9,937 | - | - | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 60,600 | - | - | Mar 31, 2024 |
| Advisors' Inner Circle Fund II | 0.00% | 20,744 | - | - | Jan 31, 2024 |
| iShares U.S. ETF Trust | 0.00% | 2,304 | - | - | Jan 31, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 59,200 | - | - | Mar 28, 2024 |
| Legg Mason Global Asset Management Trust | 0.00% | 130,000 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 2,212 | - | - | Mar 28, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 1,510 | - | - | Feb 29, 2024 |
| Brighthouse Funds Trust II | 0.00% | 12,540 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 201,129 | - | - | Mar 31, 2024 |
| MFS SERIES TRUST X | 0.00% | 113,458 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 13,086 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 3,200 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 8,408 | - | - | Dec 31, 2023 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 2,198 | - | - | Jan 31, 2024 |
| Brighthouse Funds Trust I | 0.00% | 51,800 | - | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 19,298 | - | - | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 23,294 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 530 | - | - | Jan 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 14,074 | - | - | Feb 29, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 8,808 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 10,715 | - | - | Mar 28, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 173 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 3,295 | - | - | Mar 31, 2024 |
| iShares U.S. ETF Trust | 0.00% | 120 | - | - | Jan 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 22,500 | - | - | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 11,882 | - | - | Feb 29, 2024 |
| Legg Mason Global Asset Management Trust | 0.00% | 4,342 | - | - | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 160 | - | - | Mar 31, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 39 | - | - | Jan 31, 2024 |
| iSHARES TRUST | 0.00% | 5,403 | - | - | Mar 31, 2024 |
Calithera Biosciences's largest mutual fund holder by % of total assets is "PRIMECAP Odyssey Funds", owning 7.44M shares, compromising 0.91% of its total assets.
Calithera Biosciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Dec, 22 | 1 | - |
| 30 Jun, 22 | 1 | -98.18% |
| 31 Mar, 22 | 55 | -5.17% |
| 31 Dec, 21 | 58 | -17.14% |
| 30 Sep, 21 | 70 | -13.58% |
| 30 Jun, 21 | 81 | -22.12% |
| 31 Mar, 21 | 104 | -14.75% |
| 31 Dec, 20 | 122 | 24.49% |
| 30 Sep, 20 | 98 | -12.50% |
| 30 Jun, 20 | 112 | 38.27% |
| 31 Mar, 20 | 81 | -5.81% |
| 31 Dec, 19 | 86 | -1.15% |
| 30 Sep, 19 | 87 | -6.45% |
| 30 Jun, 19 | 93 | 27.40% |
| 31 Mar, 19 | 73 | -5.19% |
| 31 Dec, 18 | 77 | -9.41% |
| 30 Sep, 18 | 85 | -8.60% |
| 30 Jun, 18 | 93 | -12.26% |
| 31 Mar, 18 | 106 | -9.40% |
| 31 Dec, 17 | 117 | 20.62% |
| 30 Sep, 17 | 97 | -2.02% |
| 30 Jun, 17 | 99 | 22.22% |
| 31 Mar, 17 | 81 | 161.29% |
| 31 Dec, 16 | 31 | -18.42% |
| 30 Sep, 16 | 38 | -13.64% |
| 30 Jun, 16 | 44 | -16.98% |
| 31 Mar, 16 | 53 | -8.62% |
| 31 Dec, 15 | 58 | 16.00% |
| 30 Sep, 15 | 50 | -5.66% |
| 30 Jun, 15 | 53 | 43.24% |
| 31 Mar, 15 | 37 | 8.82% |
| 31 Dec, 14 | 34 | - |
As of 31 Dec 22, 1 institutions are holding Calithera Biosciences's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Dec, 22 | 2 | - |
| 30 Jun, 22 | 500 | -100.00% |
| 31 Mar, 22 | 42,446,348 | 4.41% |
| 31 Dec, 21 | 40,652,493 | -11.47% |
| 30 Sep, 21 | 45,921,007 | -3.04% |
| 30 Jun, 21 | 47,363,146 | -9.98% |
| 31 Mar, 21 | 52,613,678 | -1.50% |
| 31 Dec, 20 | 53,414,285 | 1.45% |
| 30 Sep, 20 | 52,648,914 | -3.05% |
| 30 Jun, 20 | 54,305,635 | 13.55% |
| 31 Mar, 20 | 47,826,871 | -0.33% |
| 31 Dec, 19 | 47,986,981 | 35.46% |
| 30 Sep, 19 | 35,423,901 | 5.76% |
| 30 Jun, 19 | 33,493,937 | 50.52% |
| 31 Mar, 19 | 22,252,196 | 2.46% |
| 31 Dec, 18 | 21,718,918 | 8.70% |
| 30 Sep, 18 | 19,980,595 | -0.16% |
| 30 Jun, 18 | 20,012,819 | -11.17% |
| 31 Mar, 18 | 22,528,254 | -7.96% |
| 31 Dec, 17 | 24,475,995 | -5.11% |
| 30 Sep, 17 | 25,793,164 | 0.21% |
| 30 Jun, 17 | 25,739,325 | 31.71% |
| 31 Mar, 17 | 19,542,504 | 215.38% |
| 31 Dec, 16 | 6,196,443 | -25.74% |
| 30 Sep, 16 | 8,344,081 | -11.35% |
| 30 Jun, 16 | 9,412,588 | -14.46% |
| 31 Mar, 16 | 11,004,293 | -2.87% |
| 31 Dec, 15 | 11,330,017 | -16.98% |
| 30 Sep, 15 | 13,646,939 | 68.03% |
| 30 Jun, 15 | 8,121,866 | -9.45% |
| 31 Mar, 15 | 8,969,557 | -4.26% |
| 31 Dec, 14 | 9,368,445 | - |
Calithera Biosciences (CALA) has 2.00 shares outstanding as of 31 Dec 22, up 0.00% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Dec, 22 | - | - |
| 30 Jun, 22 | 0.01% | 0.00% |
| 31 Mar, 22 | 54.09% | 1.79% |
| 31 Dec, 21 | 55.04% | 1.43% |
| 30 Sep, 21 | 61.95% | 1.51% |
| 30 Jun, 21 | 63.95% | 1.21% |
| 31 Mar, 21 | 72.82% | 1.27% |
| 31 Dec, 20 | 75.67% | 1.36% |
| 30 Sep, 20 | 74.62% | 1.22% |
| 30 Jun, 20 | 78.12% | 1.42% |
| 31 Mar, 20 | 74.09% | 0.72% |
| 31 Dec, 19 | 101.43% | 2.34% |
| 30 Sep, 19 | 65.87% | 1.00% |
| 30 Jun, 19 | 81.09% | 2.47% |
| 31 Mar, 19 | 57.25% | 1.63% |
| 31 Dec, 18 | 59.33% | 1.97% |
| 30 Sep, 18 | 54.88% | 1.76% |
| 30 Jun, 18 | 55.79% | 1.41% |
| 31 Mar, 18 | 62.97% | 1.33% |
| 31 Dec, 17 | 68.83% | 1.30% |
| 30 Sep, 17 | 72.71% | 1.37% |
| 30 Jun, 17 | 72.82% | 1.22% |
| 31 Mar, 17 | 77.31% | 8.92% |
| 31 Dec, 16 | 29.44% | 1.61% |
| 30 Sep, 16 | 42.77% | 1.74% |
| 30 Jun, 16 | 49.57% | 1.38% |
| 31 Mar, 16 | 59.84% | 1.54% |
| 31 Dec, 15 | 62.38% | 1.10% |
| 30 Sep, 15 | 75.38% | 3.69% |
| 30 Jun, 15 | 45.21% | 1.81% |
| 31 Mar, 15 | 49.98% | 1.83% |
| 31 Dec, 14 | 52.21% | - |
As of 31 Dec 22, Calithera Biosciences is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 30 Jun 22.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Dec, 22 | 1 | - |
| 30 Jun, 22 | 1 | -96.00% |
| 31 Mar, 22 | 25 | -10.71% |
| 31 Dec, 21 | 28 | -9.68% |
| 30 Sep, 21 | 31 | -16.22% |
| 30 Jun, 21 | 37 | -27.45% |
| 31 Mar, 21 | 51 | -13.56% |
| 31 Dec, 20 | 59 | 51.28% |
| 30 Sep, 20 | 39 | -54.65% |
| 30 Jun, 20 | 86 | 95.45% |
| 31 Mar, 20 | 44 | -10.20% |
| 31 Dec, 19 | 49 | -3.92% |
| 30 Sep, 19 | 51 | -17.74% |
| 30 Jun, 19 | 62 | 77.14% |
| 31 Mar, 19 | 35 | 9.38% |
| 31 Dec, 18 | 32 | -3.03% |
| 30 Sep, 18 | 33 | -19.51% |
| 30 Jun, 18 | 41 | -18.00% |
| 31 Mar, 18 | 50 | -31.51% |
| 31 Dec, 17 | 73 | 46.00% |
| 30 Sep, 17 | 50 | -31.51% |
| 30 Jun, 17 | 73 | 12.31% |
| 31 Mar, 17 | 65 | 261.11% |
| 31 Dec, 16 | 18 | -5.26% |
| 30 Sep, 16 | 19 | 11.76% |
| 30 Jun, 16 | 17 | -37.04% |
| 31 Mar, 16 | 27 | -15.63% |
| 31 Dec, 15 | 32 | 23.08% |
| 30 Sep, 15 | 26 | -40.91% |
| 30 Jun, 15 | 44 | 120.00% |
| 31 Mar, 15 | 20 | -41.18% |
| 31 Dec, 14 | 34 | - |
1 institutional shareholders have increased their position in CALA stock as of 31 Dec 22 compared to 1 in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Dec, 22 | - | - |
| 30 Jun, 22 | - | -100.00% |
| 31 Mar, 22 | 13 | -27.78% |
| 31 Dec, 21 | 18 | -18.18% |
| 30 Sep, 21 | 22 | -26.67% |
| 30 Jun, 21 | 30 | -16.67% |
| 31 Mar, 21 | 36 | - |
| 31 Dec, 20 | 36 | -12.20% |
| 30 Sep, 20 | 41 | 141.18% |
| 30 Jun, 20 | 17 | -29.17% |
| 31 Mar, 20 | 24 | 9.09% |
| 31 Dec, 19 | 22 | 4.76% |
| 30 Sep, 19 | 21 | 31.25% |
| 30 Jun, 19 | 16 | - |
| 31 Mar, 19 | 16 | -44.83% |
| 31 Dec, 18 | 29 | 3.57% |
| 30 Sep, 18 | 28 | -17.65% |
| 30 Jun, 18 | 34 | 6.25% |
| 31 Mar, 18 | 32 | 33.33% |
| 31 Dec, 17 | 24 | -11.11% |
| 30 Sep, 17 | 27 | 92.86% |
| 30 Jun, 17 | 14 | 75.00% |
| 31 Mar, 17 | 8 | -11.11% |
| 31 Dec, 16 | 9 | - |
| 30 Sep, 16 | 9 | -50.00% |
| 30 Jun, 16 | 18 | 12.50% |
| 31 Mar, 16 | 16 | 45.45% |
| 31 Dec, 15 | 11 | 57.14% |
| 30 Sep, 15 | 7 | 40.00% |
| 30 Jun, 15 | 5 | -54.55% |
| 31 Mar, 15 | 11 | - |
| 31 Dec, 14 | - | - |
- institutional shareholders have reduced their position in CALA stock as of 31 Dec 22 compared to - in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Dec, 22 | 1 | - | 2 | - | - | - | 1 | - | - | - |
| 30 Jun, 22 | 1 | -98.18% | 500 | -100.00% | 0.01% | 0.00% | 1 | -96.00% | - | -100.00% |
| 31 Mar, 22 | 55 | -5.17% | 42,446,348 | 4.41% | 54.09% | 1.79% | 25 | -10.71% | 13 | -27.78% |
| 31 Dec, 21 | 58 | -17.14% | 40,652,493 | -11.47% | 55.04% | 1.43% | 28 | -9.68% | 18 | -18.18% |
| 30 Sep, 21 | 70 | -13.58% | 45,921,007 | -3.04% | 61.95% | 1.51% | 31 | -16.22% | 22 | -26.67% |
| 30 Jun, 21 | 81 | -22.12% | 47,363,146 | -9.98% | 63.95% | 1.21% | 37 | -27.45% | 30 | -16.67% |
| 31 Mar, 21 | 104 | -14.75% | 52,613,678 | -1.50% | 72.82% | 1.27% | 51 | -13.56% | 36 | - |
| 31 Dec, 20 | 122 | 24.49% | 53,414,285 | 1.45% | 75.67% | 1.36% | 59 | 51.28% | 36 | -12.20% |
| 30 Sep, 20 | 98 | -12.50% | 52,648,914 | -3.05% | 74.62% | 1.22% | 39 | -54.65% | 41 | 141.18% |
| 30 Jun, 20 | 112 | 38.27% | 54,305,635 | 13.55% | 78.12% | 1.42% | 86 | 95.45% | 17 | -29.17% |
| 31 Mar, 20 | 81 | -5.81% | 47,826,871 | -0.33% | 74.09% | 0.72% | 44 | -10.20% | 24 | 9.09% |
| 31 Dec, 19 | 86 | -1.15% | 47,986,981 | 35.46% | 101.43% | 2.34% | 49 | -3.92% | 22 | 4.76% |
| 30 Sep, 19 | 87 | -6.45% | 35,423,901 | 5.76% | 65.87% | 1.00% | 51 | -17.74% | 21 | 31.25% |
| 30 Jun, 19 | 93 | 27.40% | 33,493,937 | 50.52% | 81.09% | 2.47% | 62 | 77.14% | 16 | - |
| 31 Mar, 19 | 73 | -5.19% | 22,252,196 | 2.46% | 57.25% | 1.63% | 35 | 9.38% | 16 | -44.83% |
| 31 Dec, 18 | 77 | -9.41% | 21,718,918 | 8.70% | 59.33% | 1.97% | 32 | -3.03% | 29 | 3.57% |
| 30 Sep, 18 | 85 | -8.60% | 19,980,595 | -0.16% | 54.88% | 1.76% | 33 | -19.51% | 28 | -17.65% |
| 30 Jun, 18 | 93 | -12.26% | 20,012,819 | -11.17% | 55.79% | 1.41% | 41 | -18.00% | 34 | 6.25% |
| 31 Mar, 18 | 106 | -9.40% | 22,528,254 | -7.96% | 62.97% | 1.33% | 50 | -31.51% | 32 | 33.33% |
| 31 Dec, 17 | 117 | 20.62% | 24,475,995 | -5.11% | 68.83% | 1.30% | 73 | 46.00% | 24 | -11.11% |
| 30 Sep, 17 | 97 | -2.02% | 25,793,164 | 0.21% | 72.71% | 1.37% | 50 | -31.51% | 27 | 92.86% |
| 30 Jun, 17 | 99 | 22.22% | 25,739,325 | 31.71% | 72.82% | 1.22% | 73 | 12.31% | 14 | 75.00% |
| 31 Mar, 17 | 81 | 161.29% | 19,542,504 | 215.38% | 77.31% | 8.92% | 65 | 261.11% | 8 | -11.11% |
| 31 Dec, 16 | 31 | -18.42% | 6,196,443 | -25.74% | 29.44% | 1.61% | 18 | -5.26% | 9 | - |
| 30 Sep, 16 | 38 | -13.64% | 8,344,081 | -11.35% | 42.77% | 1.74% | 19 | 11.76% | 9 | -50.00% |
| 30 Jun, 16 | 44 | -16.98% | 9,412,588 | -14.46% | 49.57% | 1.38% | 17 | -37.04% | 18 | 12.50% |
| 31 Mar, 16 | 53 | -8.62% | 11,004,293 | -2.87% | 59.84% | 1.54% | 27 | -15.63% | 16 | 45.45% |
| 31 Dec, 15 | 58 | 16.00% | 11,330,017 | -16.98% | 62.38% | 1.10% | 32 | 23.08% | 11 | 57.14% |
| 30 Sep, 15 | 50 | -5.66% | 13,646,939 | 68.03% | 75.38% | 3.69% | 26 | -40.91% | 7 | 40.00% |
| 30 Jun, 15 | 53 | 43.24% | 8,121,866 | -9.45% | 45.21% | 1.81% | 44 | 120.00% | 5 | -54.55% |
| 31 Mar, 15 | 37 | 8.82% | 8,969,557 | -4.26% | 49.98% | 1.83% | 20 | -41.18% | 11 | - |
| 31 Dec, 14 | 34 | - | 9,368,445 | - | 52.21% | - | 34 | - | - | - |
Calithera Biosciences Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Calithera Biosciences's stock was made by TAKEDA PHARMACEUTICAL CO LTD on May 26 2023, selling 1,000,000 shares at $40.08 per share (valued at $40.08M).
Calithera Biosciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2023 | - | 6 | - |
| Q3 2022 | 1 | 1 | 100.00% |
| Q2 2022 | 7 | - | - |
| Q1 2022 | 8 | 8 | 100.00% |
| Q4 2021 | 16 | 16 | 100.00% |
| Q2 2021 | 8 | - | - |
| Q1 2021 | 23 | - | - |
| Q4 2020 | - | 1 | - |
| Q3 2020 | 1 | 1 | 100.00% |
| Q2 2020 | 7 | 4 | 175.00% |
| Q1 2020 | 8 | 1 | 800.00% |
| Q4 2019 | 12 | 1 | 1200.00% |
| Q2 2019 | 12 | 9 | 133.33% |
| Q1 2019 | 8 | 4 | 200.00% |
| Q4 2018 | 1 | 4 | 25.00% |
| Q2 2018 | 8 | 1 | 800.00% |
| Q1 2018 | 14 | 7 | 200.00% |
| Q4 2017 | 4 | 6 | 66.67% |
| Q3 2017 | 2 | 8 | 25.00% |
| Q2 2017 | 6 | 1 | 600.00% |
0 total buy trades, and 6 total sell trades (buy/sell ratio of 0.00%) were made by Calithera Biosciences's insiders, as of Q1 2023.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2023 | - | 1 | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 3 | 3 | 100.00% |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | 1 | - |
| Q3 2020 | - | - | - |
| Q2 2020 | - | 4 | - |
| Q1 2020 | - | 1 | - |
| Q4 2019 | 12 | 1 | 1200.00% |
| Q2 2019 | 2 | 3 | 66.67% |
| Q1 2019 | - | 2 | - |
| Q4 2018 | - | 2 | - |
| Q2 2018 | - | - | - |
| Q1 2018 | - | - | - |
| Q4 2017 | - | - | - |
| Q3 2017 | - | 6 | - |
| Q2 2017 | - | 1 | - |
As of Q1 2023, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Calithera Biosciences's stocks.
Calithera Biosciences Peer Ownership
| Ticker | Company |
|---|---|
| CKPT | Checkpoint Therapeutics, Inc. |
| MREO | Mereo BioPharma Group plc |
| ABEO | Abeona Therapeutics Inc. |
| PDSB | PDS Biotechnology Corporation |
| VSTM | Verastem, Inc. |
| ADAP | Adaptimmune Therapeutics plc |
| ARDX | Ardelyx, Inc. |
| AVRO | AVROBIO, Inc. |
| GLMD | Galmed Pharmaceuticals Ltd. |
| KOD | Kodiak Sciences Inc. |
| AFMD | Affimed N.V. |
| ADVM | Adverum Biotechnologies, Inc. |
| LPTX | Leap Therapeutics, Inc. |
| PIRS | Pieris Pharmaceuticals, Inc. |
| HEPA | Hepion Pharmaceuticals, Inc. |
| ZURA | Zura Bio Limited |
CALA Ownership FAQ
Who Owns Calithera Biosciences?
Calithera Biosciences is owned by institutional shareholders (0%), insiders (1.07%), and public (0%). The largest institutional shareholder of Calithera Biosciences is FINTRUST CAPITAL ADVISORS, LLC (0.02% of total shares) and the top mutual fund owner is PRIMECAP Odyssey Funds (0.91% of total shares).
Who are the major institutional shareholders of Calithera Biosciences?
Calithera Biosciences's major institutional shareholders are FINTRUST CAPITAL ADVISORS, LLC, MORGAN STANLEY, CITADEL ADVISORS LLC, UBS GROUP AG, and BANK OF AMERICA CORP /DE/. The top five shareholders own together 0.02% of the company's share outstanding.
How many Calithera Biosciences shareholders are there?
As of Dec 2022, there are 1 institutional shareholders of Calithera Biosciences.
What percentage of Calithera Biosciences is owned by FINTRUST CAPITAL ADVISORS, LLC?
FINTRUST CAPITAL ADVISORS, LLC owns 1.2K shares of Calithera Biosciences, representing 0.02% of the company's total shares outstanding, valued at $3.92M (as of Mar 2023).
What percentage of Calithera Biosciences is owned by MORGAN STANLEY?
As of Mar 2023, MORGAN STANLEY holds 0 shares of Calithera Biosciences (CALA), compromising 0% of the company, valued at $0.
What percentage of Calithera Biosciences is owned by CITADEL ADVISORS LLC?
CITADEL ADVISORS LLC is the third largest holder of Calithera Biosciences. The company owns 0 of the company's shares outstanding (worth $0).